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Abstract: Sensitivity is the main concern at the development of rapid test by lateral 24 
flow immunoassays. On the other hand, low limits of detection are often required at 25 
medical diagnostics and other field of analysis. To overcome this drawback, several 26 
enhancement protocols have been described. In this paper, we have selected different 27 
silver enhancement methods and one dual gold conjugation, and we critically compared 28 
the amplification produced when applied to a gold-nanoparticle based lateral flow 29 
immunoassay for the detection of prostate specific antigen (PSA). The highest 30 
amplification was obtained by using an immersion method based on a solution of silver 31 
nitrate and hydroquinone/citrate buffer in proportion 1:1. Under these conditions, the 32 
system is capable of detecting PSA within 20 min at levels as low as 0.1 ng/mL, with a 33 
3-fold sensitivity improvement .  34 
Keywords: Lateral Flow Immunoassay Dipstick, Enhancement procedures, Silver 35 
enhancement, Dual gold conjugate 36 
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1. Introduction 45 
Nowadays, there is a need to develop rapid, simple, and cost-effective tests capable of 46 
being performed by unskilled operators in areas such as diagnosis of diseases in 47 
developing countries or emergency rooms [1]. In this way, lateral flow immunoassay 48 
test (LFIA) represent a well-established and very appropriate technology when applied 49 
to a wide variety of point-of-care (POC) or in-field use applications. However, the 50 
detection sensitivity of the LFIA is lower than the others immunoassays based on 51 
fluorescent, radioactive, and enzyme-colorimetric methods (ELISA) [2] and a higher 52 
sensitivity is often required in medical diagnostics. Many studies have attempted to 53 
improve the sensitivity of the immunoassay, such as by using different labels (colloidal 54 
metal nanoparticles [3-6], enzymes [7-9], magnetic beads [10-12], quantum dots [13-55 
14], etc.), coupling with transducters or by amplifying the detection signals.  Gold 56 
nanoparticles (AuNP) are commonly used because they can be easily conjugated with 57 
biomolecules.  Furthermore, they allow signal amplification in biosensing where they 58 
serve as labels [15]. One strategy to follow in order to enhance the signal is the use of 59 
larger nanoparticles. However,  while colloidal gold particles smaller than 15 nm were 60 
found to be too small for producing an intense color, AuNP larger than 60-70 nm are 61 
more unstable, forming aggregates after several days of storage at 4ºC [16]. They also 62 
require larger concentrations of antibodies in the conjugation, increasing costs. Tang et 63 
al. [17] developed a novel LFIA for the screening of aflatoxin B2 in food samples. The 64 
detector reagent consisted of magnetic nanogold microspheres (with nano-Fe2O3 65 
particles as core and AuNP as shell) bio-functionalized with monoclonal anti-AFB2 66 
antibodies. The visual detection limit obtained with this approach was about threefold 67 
lower compared to a conventional immunodipstick test using AuNP. Parolo et al. [18] 68 
discussed the development of an enhanced LFIA based on the use of AuNP in 69 
combination with the enzymatic activity of the HRP when it is coupled to the detection 70 
antibody. A detection limit of 310 pg/mL was achived using this approach. Recently, H. 71 
Chon et al. [19] have carried out a similar approach using AuNP-assisted enzyme for 72 
detection of pathogens in food, adding the substrate in the cross-flow direction. With 73 
this approach, the limit of detection can be increased by about 1000-fold. AuNP can act 74 
as a catalyst and reduce copper and especially silver ions into their respective metals in 75 
the presence of a reducing agent. The reaction leads to the deposition of copper and 76 
silver on the gold surface as nucleation site and enlargement of the size of AuNP, 77 
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resulting in a remarkable signal amplification in the test and control line of the 78 
immunostrip [20]. The silver staining can be carried out in an incubation mode by 79 
immersing the membrane in the enhancement silver after performance the LFIA [21]. 80 
Silver enhancement technology was developed by Yang et al. [22] based on the use of 81 
two pads where AgNO3 and the reduction agent were fixed. These two approaches have 82 
the inconvenient of involving additional operation steps in the assay, increasing the time 83 
and the difficulty to use them outside of the laboratory. To overcome this technical 84 
limitation Choi et al. [23] developed a new method to detect Troponin I utilizing two 85 
AuNP-antibody conjugates in different pads. The 1st AuNP conjugate was blocked with 86 
BSA and it was immobilized at the conjugate pad with an antibody against the antigen 87 
chosen. The 2nd AuNP anti-BSA conjugate was designed to bind only with the 1st 88 
AuNP conjugate and to enhance the signal. The LFIA method developed in this study is 89 
useful since it is a rapid one step analysis with a signal 100-fold more sensitive than the 90 
normal LFIA. Similarly, Wiriyachaiporn et al. [24] have recently proposed a double-91 
targeted nanogold using the 2nd gold conjugate with anti-biotin instead of anti-BSA. 92 
With this approach they demonstrated a 4-fold lower LOD in the detection of influenza 93 
virus.  Other approaches based on the use of two different AuNPs make use of DNA as 94 
crosslinker agent [25,26].   95 
         In this study, one new protocol of silver enhancement was developed with the aim 96 
of amplifying the signal of colloidal gold on the test strip after the standard assay, 97 
avoiding therefore the silver solution handling by the end user. This consisted on 98 
immobilizing the silver salt in a separated pad. Results were compared with those 99 
obtained by using other protocols reported at the literature. The thick silver layer on the 100 
gold nanoparticles endowed particular features, such as colorimetric, electrical and 101 
electrochemical properties for quantitative biosensing [27]. Silver has been used as 102 
electrochemical label for immunoassays [28,29],  and therefore this protocol could be 103 
useful to explore the coupling of the strip with an electrochemical transducer in future 104 
work. A novel gold enhancement system was also developed based on the use of biotin-105 
neutravidin bridge. While other methods reported in the literature use secondary 106 
antibodies such as anti-BSA or anti-biotin to perform the amplification [23, 24], in this 107 
work a new method is presented, potentially more advantageous than others reported 108 
previously, because it involves a neutravidin protein instead a specific antibody. As a 109 
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model antigen for this immunoassay research, prostate specific antigen (PSA), 110 
biomarker of prostate cancer, was used.    111 
    112 
2.  Material and methods 113 
2.1. Chemicals and reagents 114 
Mouse monoclonal anti-PSA antibodies HS-5 (capture antibody) and HS-8 (detection 115 
antibody) were produced by Healthsens (Oviedo, Spain). Anti-mouse IgG was 116 
purchased from Sigma-Aldrich (Spain). PSA standard solution, calibrated against 117 
International Standard Stamey 9010 was obtained from Fujirebio Diagnosis. Gold 118 
nanoparticles (AuNP) of 40-nm and 20-nm were purchased from BBInternational (UK) 119 
to conjugate the antibody or neutravidin. Bovine serum albumin (BSA), Biotin-120 
conjugated bovine serum albumin, AgNO3, hydroquinone, citric acid monohydrate and 121 
sodium citrate dehydrate were purchased by Sigma-Aldrich. Neutravidin was purchased 122 
by Thermo Fischer Scientific (Massachusetts,USA). Other reagents used in this study 123 
were of analytical grade. 124 
Nitrocellulose membranes (UniSart CN95) were purchased from Sartorius (Spain). 125 
Other materials used were: glass fiber sample pads (GFCP001000, Millipore, 126 
Germany), backing cards (KN-V1080, Kenoshatapes, Netherlands) and absorbent pads 127 
(Whatman, USA). 128 
Based on previous results, the sample buffer consisted of 10mM PBS pH 7.4 with 129 
0.05% Tween-20 and 2% BSA.     130 
2.2. Equipment      131 
An IsoFlow reagent dispensing system (Imagene Technology, USA) was used to 132 
dispense the detection line. A guillotine Fellowes Gamma (Spain) was used to cut the 133 
strips. To analyze the enhancement procedure, the strip was scanned before and after 134 
this step using a HP Officejet Pro 8500A scan. The optical density of the capture image 135 
from the signal monitoring window was digitized using ImageJ 1.48v software.  136 
 137 
 138 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
2.3. Labelling antibody with colloidal gold 139 
The desirable concentration of the antibody to stabilize the gold nanoparticles was 140 
found following the titration of gold colloid procedure as described in reference [30]. 141 
Then, 100L of 150 g/mL HS-8 anti-PSA was added to 1.5mL of gold solution. After 142 
shaking for 1h, 100L of the blocking solution Biotin-conjugated BSA (40% v/v ; 143 
prepared by mixing 40 L of 1 mg/mL Biotin-conjugated BSA with 60 L of 1 mg/mL 144 
BSA in phosphate buffer (PBS 10mM, pH 7.4)  was added to the mixture to block the 145 
residual surfaces of antibody-colloidal gold conjugated. After 20 min of reaction, the 146 
solution was centrifuged at 10,000 rpm for 20 min. The supernatant was discarded and 147 
the pellet was resuspended in PBS with 10% sucrose and 1% BSA (100 L).  The 148 
product (AuNPs-HS-8 conjugate) was then stored at 4ºC until used.  149 
2.4. Characterization of nanoparticles conjugates 150 
Size distribution and -potential were carried out with a Zetasizer Nano ZS (Malvern) 151 
equipped with a solid-state He-Ne laser (= 633) for monitoring the conjugation 152 
process.  153 
2.5. Preparation of immunostrip 154 
The nitrocellulose membrane (NC, 25 mm-wide) was incorporated onto a plastic 155 
backing card to give robustness to the membrane. The test zone of the strip was 156 
prepared dispensing a desired volume of 1 mg/mL mouse monoclonal HS-5 anti-PSA 157 
and anti-IgG to form the test (T) and control (C) lines respectively with the dispenser 158 
IsoFlow onto NC membrane at a dispensing rate of 0.100 L/mm and was dried for 20 159 
min at 37ºC. The sample pad and the absorbent pad were then settled onto the backing 160 
card with an overlap between them of around 2 mm. The complete strip was cut into 161 
individual 4 mm strips. The strip was assembled as describe in Figure 1. 162 
2.6. Lateral flow immunoassay 163 
PSA standard solutions at concentrations of 0, 0.1, 0.5, 1, 4 and 10 ng/mL were 164 
prepared by diluting a PSA stock solution in the sample buffer. The amount of BSA and 165 
Tween-20 was optimized for this assay, obtaining the best results when 2% BSA and 166 
0.05% Tween-20 were added to the PBS. The volume of AuNPs-HS8 conjugate was 167 
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also optimized, looking for a compromise between sensitivity and reagent costs.  For 168 
dipstick analysis, samples were transferred into the microtube containing 10 L of 169 
AuNPs-HS-8 conjugate and homogenized (final volume 100 L). Then the dipstick was 170 
added into the microtube and the sample was allowed to run for 10 min (Figure 1). The 171 
performance of the immunostrip relied on non-competitive assay formats. PSA in the 172 
sample was sandwiched between an anti-PSA antibody immobilized on the strip (Test 173 
line, T) and the AuNP-conjugated antibody. The unbound AuNP-conjugates migrated 174 
further to be captured by anti-mouse immunoglobulin antibodies (Control, C) for 175 
system functional verification. Once the test was run, the line intensities were recorded 176 
by scanning the images.  177 
[ FIGURE 1] 178 
2.7. Silver enhancement procedure  179 
2.7.a. Immersion 180 
The immersion protocol for silver enhancement was carried out according to the 181 
literature with some variations [31].  A solution of silver nitrate (0.3 % w/v in water) 182 
and other of hydroquinone (3 % w/v in 0.5 M citrate buffer pH 4.0) were prepared and 183 
stored at room temperature in the dark. Just before use, the enhancing solution was 184 
freshly prepared by 1:1 mixing of the two solutions. 10 min after the addition of the 185 
sample, the NC strip was dipped into the microtube containing 100 L of this solution 186 
for 10 min. The strip was then scanned to analyze the signal intensity.  187 
2.7.b. Sandwich immunochromatographic assay 188 
The protocol was executed as described elsewhere [22]. A glass fiber pad (4x10 mm) 189 
was washed with distilled water and immersed in a silver nitrate solution (0.3 % w/v in 190 
water). Another pad with the same dimensions was saturated with the reducing agent 191 
(3% w/v hydroquinone in 0.5 M citrate buffer pH 4.0). Both pads were dried at room 192 
temperature in the dark and kept in those conditions until use. After 10 min of the 193 
sample adding, the test zone on the NC membrane was covered by the silver pad, and 194 
then the reducer pad was placed above it. Once the pads were located forming a 195 
sandwich in the strip, 100 L of distilled water was added to the pads. After 10 min, the 196 
strip was scanned to measure the optical density of the stain.  197 
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2.7.c. Conjugated pad modified with silver 198 
In order to perform this assay, the silver salt for silver enhancement was incorporated 199 
into the device itself. A glass fiber sample pad (4x10 mm) was washed with different 200 
solutions to study the release of the silver from the pad and was immersed in a silver 201 
nitrate solution (0.3 % w/v in water). It was dried at room temperature in the dark and 202 
placed in the strip in the place of the sample pad. The strip should be kept in the dark 203 
until use. The test was carried out as described in part 2.5. After running the test, 50 μl 204 
of 3 % w/v hydroquinone in 0.5 M citrate buffer pH 4.0 were added in the microtube. 205 
Line intensities were recorded by scanning images after 10 min.  206 
 207 
2.8. Gold enhancement procedure  208 
In this assay, two AuNP conjugates were used. The first conjugate contained a 209 
monoclonal antibody against the analyte in the same way as in previous assays. The 210 
second conjugate is prepared by conjugation of 20-nm AuNP with neutravidin (the 211 
conjugation protocol is the same that in the case of AuNP with HS-5 described in part 212 
2.3, after the optimization of the neutravidin concentration required to stabilize the 213 
gold). This procedure was designed to bind only the first primary AuNP conjugate to 214 
improve the signal. The test was carried out as described in part 2.5. Once the test was 215 
run, 8 L AuNP-neutravidin conjugate, previously optimized, was added to the 216 
microtube containing PBS buffer with 0.05% Tween (final volume 50 L).  Line 217 
intensities were recorded by scanning images after 10 min. 218 
3. Results and Discussion 219 
3.1. Characterization of nanoparticles conjugates 220 
Dynamic Light Scattering (DLS) measurements were carried out to confirm the 221 
conjugation reaction between the gold nanoparticles and the antibody or neutravidin in 222 
each case. This technique allows monitoring the size variation of the nanoparticles after 223 
the conjugation reaction. Comparing with TEM, the DLS values are expected to be 224 
larger due to the double layer which goes into the calculations of the hydrodynamic 225 
diameter of the particles in solution.  The results showed that the hydrodynamic sizes of 226 
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the conjugates were 85.60 nm (PDI 0.180) and 43.88 (PDI 0.230) for AuNP-HS8 and 227 
AuNP-Neutravidin respectively. The data from DLS shows that the conjugates are 228 
monodisperse (Figure 2). The absence of additional peaks, together with the PDI value 229 
obtained, indicate the not presence of aggregates in the solution. The radious observed 230 
following conjugation is consistent with the steps carried out, including blocking with 231 
BSA. 232 
To determinate their stability, -potential measures were carried out. To remain stable, 233 
they must have enough repulsion to keep the particles apart. The results showed a -234 
potential of -20 mV and -23 mV for AuNP-HS8 and AuNP-Neutravidin respectively, 235 
indicating that the conjugates were stable.  236 
[FIGURE 2] 237 
3.2. Silver immobilization optimization 238 
The first step to carry out the silver enhancement was to study the silver immobilization 239 
process itself. In order to optimize the silver release from the sample pad, it was treated 240 
with different solutions before the immobilization process (water, PBS 10mM with 241 
0.05% Tween and PBS 10mM with 1%BSA). Only in the case that the sample pad was 242 
treated with BSA, the grey signal produced when the hydroquinone/citrate solution was 243 
added in the second step appeared. This could be explained because in the others 244 
methods either the immobilization process was less effective or the silver was strongly 245 
bond to the sample pad and couldn’t be released from it.  Additional experiments were 246 
carried out by modifying the sample pad with PBS 10mM with 1%BSA before the 247 
silver immobilization. 248 
3.3.  Gold enhancement procedure  249 
Different volumes of AuNP-Neutravidin and different sample buffers were tested in 250 
order to obtain the higher amplification. The best results were obtained when 8 L of 251 
AuNP-Neutravidin were added to PBS buffer with 0.05% Tween. Higher volumes 252 
resulted in a high background, hindering the signal.   253 
 254 
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3.4. Comparison of enhancement procedures 256 
We compared four signal ampliﬁcation methods involving gold, silver or both: 257 
Immersion in silver hydroquinone/citrate solution, Sandwich immunochromatographic 258 
assay, Conjugated pad modified with silver and Gold enhancement procedure (Figure 259 
3).  In order to compare these different enhancement strategies, and based in previous 260 
experiments, we selected a low PSA concentration, which produced a weak red line in 261 
the test line, almost undetectable when it was scanned. The concentration chosen was  262 
0.5 ng/mL. All the assays were performed by triplicate and were scanned in grey scale 263 
with a scan resolution of 2400ppp. The results are shown in  Figure 4. The test line 264 
intensity was analyzed using ImageJ software. 265 
 266 
[FIGURE 3 and 4] 267 
 268 
Referring to Figure 4, we see that, basing on naked-eye, the higher amplification was 269 
obtained using the immersion method. These results were confirmed using the ImageJ 270 
software, which showed 3-fold amplification related to the signal obtained when only 271 
gold is used. The optical density in this case is higher than in the other amplification 272 
methods. The results obtained when the sandwich method was used were good too, but 273 
the process is more tedious because it needs more user manipulation to put the two 274 
modified pads over the test and control lines. Moreover, it produces a higher 275 
background that in the case of the immersion. When silver is immobilized in the 276 
conjugate, the signal obtained in the test line is not homogeneous when the first binding 277 
assay with AuNP-HS8 is carried out. This is probably due to the non-homogeneous 278 
presence of BSA and silver nitrate in the sample pad. This effect also results in a lower 279 
sensitivity even before the enhancement step. The assay performed using two gold 280 
nanoparticles produced good results. However, they do not reach the amplification level 281 
of the silver immersion method. This approach has got the advantage of that it can be 282 
performed in a single step, mixing the two conjugates in the microtube before dipping 283 
the strip in . The amplification, however, is a bit worst, due probably to some steric 284 
impediments. 285 
In view of these results, it can be concluded that the immersion in silver and 286 
hydroquinone/citrate solution produced low background, and yielded a relatively strong 287 
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signal, in a simple step consisting in mixing two solutions previously prepared. 288 
Therefore this was selected as the best ampliﬁcation method for further assays. A 289 
photograph showing the red and grey-dark test and control lines produced by both gold 290 
(primary) and the best silver enhancement method is shown in  Figure 5. 291 
[ FIGURE 5] 292 
 293 
3.5. Calibration curve with silver enhancement 294 
Several standards were prepared by spiking the buffer solution with various 295 
concentrations of PSA, and they were assayed by the test strip. Detection limit for the 296 
first step (AuNP-HS8 as label) was 0.5 ng/mL by eye-naked. To improve detection 297 
limit, the tested strip was dipped in the silver enhancer solution. Using this approach, 298 
0.1 ng/ml of PSA was easily detected by naked-eye. Very low non-specific binding is 299 
shown in the absence of PSA in the silver enhancement step. The line intensities were 300 
recorded before and after the silver enhancement using the HP scan and the intensities 301 
were measured using ImageJ software. Results are comparatively shown in Figure 6. 302 
 303 
[ FIGURE 6] 304 
 305 
 306 
4. Conclusion 307 
An enhanced lateral flow immunoassay was successfully developed using different 308 
silver staining and one dual gold method as signal amplification strategy to detect PSA. 309 
The best results were obtained when the strip was dipped in a second step in a solution 310 
containing silver nitrate and hydroquinone/citrate buffer in proportion 1:1. A 3-fold 311 
improvement in sensitivity with a detection limit of 0.1 ng/mL of PSA could be 312 
achieved by using this approach. The proposed method is simple, convenient, and low 313 
cost. The performance of the assay was simple and can be completed in 20 minutes. 314 
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This study demonstrated a proof-of-concept of different LFIA amplification procedures, 315 
which could be potentially used in other applications.  316 
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 437 
Figure  1.   438 
A) Schematic representation of the Lateral Flow Immunoassay Dipstick. Specific 439 
antibodies against prostate specific antigen (PSA) (Test, T) and anti-mouse 440 
immunoglobulin antibodies (Control, C) are immobilized on the membrane. B) 441 
Detection of PSA before the amplification procedure. PSA, if present in the sample, 442 
form a complex with AuNP-conjugated antibodies and are captured onto the membrane 443 
by the immobilized antibodies. C)  Dipstick procedure for sample analysis 444 
 445 
 446 
Figure  2.  . 447 
 Hydrodynamic size distribution profiles of different gold nanoparticles solutions before 448 
(denoted as AuNP 40 nm and AuNP 20 nm) and after the conjugation with antibody or 449 
neutravidin (denoted as AuNP-HS8 and AuNP-Neu, respectively) 450 
 451 
 452 
Figure 3.  453 
 A) Silver enhancement procedure. Reducing reagent and silver ions are applied on the 454 
membrane and silver clusters are formed around the AuNP.  B) Gold enhancement 455 
procedure. A second AuNP-conjugated is added on the membrane and it binds with the 456 
AuNP-conjugated antibody immobilized in the test line.    457 
 458 
Figure 4.   459 
Results obtained by enhancement process. In each cell of the table, the strip before the 460 
amplification process is on the left, and the strip after the amplification is on the right. 461 
The strips are accompanied by corresponding signal intensity peaks generated by 462 
ImageJ software A) Immersion. B) Sandwich immunochromatographic assay. C) 463 
Conjugated pad modified with silver. D) Gold enhancement procedure. Bottom row 464 
show the amplification obtained in each case. Both images and the image analysis are 465 
representative of three individual experiments. 466 
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Figure 5. Comparison of the test lines obtained in a Lateral Flow Immunoassay 469 
Dipstick for PSA (0.5 ng/mL). A) Antibody labelled with AuNP (40nm). B) Silver 470 
enhancement signal using the immersion method 471 
 472 
 473 
Figure 6 Detection of PSA with varying concentrations by LFIA Dipstick and the silver 474 
enhancement by immersion. The data points were obtained in triplicate and error bars 475 
represent the standard deviations of triplicate runs. Representative examples of results 476 
obtained in the strips before and after the silver enhancement process are shown on the 477 
right. 478 
 479 
 480 
 481 
 482 
  
 
Fig. 1 A) Schematic representation of the Lateral Flow Immunoassay Dipstick. 
Specific antibodies against prostate specific antigen (PSA) (Test, T) and anti-mouse 
immunoglobulin antibodies (Control, C) are immobilized on the membrane. B) 
Detection of PSA before the amplification procedure. PSA, if present in the 
sample, forms a complex with AuNP-conjugated antibodies and are captured onto 
the membrane by the immobilized antibodies. C)  Dipstick procedure for sample 
analysis 
 
Figure1
 Fig 2. Hydrodynamic size distribution profiles of different gold nanoparticles 
solutions before (denoted as AuNP 40 nm and AuNP 20 nm) and after the 
conjugation with antibody or neutravidin (denoted as AuNP-HS8 and AuNP-Neu, 
respectively) 
 
Figure2
 Fig. 3A) Silver enhancement procedure. Reducing reagent and silver ions are 
applied on the membrane and silver clusters are formed around the AuNP.  B) 
Gold enhancement procedure. A second AuNP-conjugated is added on the 
membrane and it binds with the AuNP-conjugated antibody immobilized in the 
test line.    
Figure3
 Fig. 4. Results obtained by enhancement process. In each cell of the table, the strip 
before the amplification process is on the left, and the strip after the amplification 
is on the right. The strips are accompanied by corresponding signal intensity peaks 
generated by ImageJ software A) Immersion. B) Sandwich 
immunochromatographic assay. C) Conjugated pad modified with silver. D) Gold 
enhancement procedure. Bottom row show the amplification obtained in each case. 
Both images and the image analysis are representative of three individual 
experiments. 
 
Figure4
 Fig.  5. Comparison of the test lines obtained in a Lateral Flow Immunoassay 
Dipstick for PSA (0.5 ng/mL). A) Antibody labelled with AuNP (40nm). B) Silver 
enhancement signal using the immersion method.  
 
Figure5
 Fig. 6. Detection of PSA with varying concentrations by LFIA Dipstick and the 
silver enhancement by immersion. The data points were obtained in triplicate and 
error bars represent the standard deviations of triplicate runs. Representative 
example of results obtained in the strips before and after the silver enhancement 
process is shown on the right.  
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